ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.785
+0.135 (8.20%)
Nov 21, 2024, 1:29 PM EST - Market open

ProKidney Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
40.5844.8270.948.865.984.16
Research & Development
110.42106.7182.0746.2621.0415
Operating Expenses
150.99151.52153.0155.1127.0219.16
Operating Income
-150.99-151.52-153.01-55.11-27.02-19.16
Interest Expense
-0.01-0.01-0.22---
Interest & Investment Income
20.2422.085.9800.040.13
EBT Excluding Unusual Items
-130.76-129.45-147.24-55.11-26.98-19.03
Pretax Income
-136.09-129.45-147.24-55.11-26.98-79.25
Income Tax Expense
0.4960.90.04-0.230.36
Earnings From Continuing Operations
-136.58-135.45-148.14-55.15-26.75-79.62
Minority Interest in Earnings
90.9799.9840.1---
Net Income
-45.61-35.47-108.03-55.15-26.75-79.62
Preferred Dividends & Other Adjustments
---93.63---
Net Income to Common
-45.61-35.47-14.4-55.15-26.75-79.62
Shares Outstanding (Basic)
81626215110579
Shares Outstanding (Diluted)
81626215110579
Shares Change (YoY)
32.24%0.28%-59.17%43.55%33.70%-
EPS (Basic)
-0.56-0.57-0.23-0.37-0.25-1.01
EPS (Diluted)
-0.56-0.57-0.23-0.37-0.25-1.01
Free Cash Flow
-133.14-124.27-78.94-55.49-30.64-78.11
Free Cash Flow Per Share
-1.64-2.01-1.28-0.37-0.29-0.99
EBITDA
-145.99-147.67-149.97-53.13-26.06-18.29
D&A For EBITDA
53.853.041.980.960.87
EBIT
-150.99-151.52-153.01-55.11-27.02-19.16
Source: S&P Capital IQ. Standard template. Financial Sources.